ctDNA and the Enduring Role of Value-Based Models: Lalan Wilfong, MD
Lalan Wilfong, MD, of Thyme Care and Texas Oncology, discusses a session on circulating tumor DNA (ctDNA) and shares insight as chair of the Community Oncology Alliance (COA) Payer Reform Committee.
State Legislatures Lead the Way on Policy Reform to Protect Personalized Medicine
Practice Radiation Patterns Among Oncologists in the Oncology Care Model
Despite the potential incentives for medical oncologists to reduce radiation therapy utilization under the Oncology Care Model, we find no evidence that such reduction occurred.
Telemedicine for Cancer Care: Implementation Across a Multicenter Community Oncology Practice
Texas Oncology physicians discuss utilization of telemedicine, evaluating trends, barriers, and opportunities in care delivery during the coronavirus disease 2019 pandemic.
